Transcription of Revised monoclonal antibody (mAb) …
{{id}} {{{paragraph}}}
Example: stock market
Revised monoclonal antibody (mAb) …
INN Working Doc. M ay 2017 Distr.: GENERAL ENGLISH ONLY Revised monoclonal antibody (mAb) nomenclature scheme Geneva, 26 May 2017 Programme on International Nonproprietary Names (INN) Technologies Standards and Norms Regulation of Medicines and other Health Technologies (RHT) Essential Medicines and Health Products (EMP) World Health Organization, Geneva World Health Organization 2017 The designations employed and the presentation of the material in this publication do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries.
WHO International Nonproprietary Names Programme 1 Revised monoclonal antibody (mAb) nomenclature scheme International Nonproprietary Names (INN) facilitate the identification of pharmaceutical
Loading..
Tags:
Information
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document: